311 related articles for article (PubMed ID: 17614818)
1. Inhibitor development in haemophilia B: an orphan disease in need of attention.
DiMichele D
Br J Haematol; 2007 Aug; 138(3):305-15. PubMed ID: 17614818
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997-2006).
Chitlur M; Warrier I; Rajpurkar M; Lusher JM
Haemophilia; 2009 Sep; 15(5):1027-31. PubMed ID: 19515028
[TBL] [Abstract][Full Text] [Related]
3. Development of anaphylactic shock in haemophilia B patients with inhibitors.
Warrier I; Lusher JM
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S125-8. PubMed ID: 9819043
[TBL] [Abstract][Full Text] [Related]
4. Immune tolerance in haemophilia: the long journey to the fork in the road.
DiMichele DM
Br J Haematol; 2012 Oct; 159(2):123-34. PubMed ID: 22924753
[TBL] [Abstract][Full Text] [Related]
5. Incidence of factor IX inhibitor development in severe haemophilia B patients treated with only one brand of high purity plasma derived factor IX concentrate.
Parquet A; Laurian Y; Rothschild C; Navarro R; Guérois C; Gay V; Durin A; Peynet J; Sultan Y
Thromb Haemost; 1999 Oct; 82(4):1247-9. PubMed ID: 10544907
[TBL] [Abstract][Full Text] [Related]
6. Immune tolerance: critical issues of factor dose, purity and treatment complications.
DiMichele DM
Haemophilia; 2006 Dec; 12 Suppl 6():81-5; discussion 85-6. PubMed ID: 17123399
[TBL] [Abstract][Full Text] [Related]
7. Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors.
Astermark J; Morado M; Rocino A; van den Berg HM; von Depka M; Gringeri A; Mantovani L; Garrido RP; Schiavoni M; Villar A; Windyga J;
Haemophilia; 2006 Jul; 12(4):363-71. PubMed ID: 16834735
[TBL] [Abstract][Full Text] [Related]
8. A retrospective study to describe the incidence of moderate to severe allergic reactions to factor IX in subjects with haemophilia B.
Recht M; Pollmann H; Tagliaferri A; Musso R; Janco R; Neuman WR
Haemophilia; 2011 May; 17(3):494-9. PubMed ID: 21518148
[TBL] [Abstract][Full Text] [Related]
9. Successful second ITI with factor IX and combined immunosuppressive therapy. A patient with severe haemophilia B and recurrence of a factor IX inhibitor.
Holstein K; Schneppenheim R; Schrum J; Bokemeyer C; Langer F
Hamostaseologie; 2014; 34 Suppl 1():S5-8. PubMed ID: 25382771
[TBL] [Abstract][Full Text] [Related]
10. Rituximab in the treatment of alloimmune factor VIII and IX antibodies in two children with severe haemophilia.
Mathias M; Khair K; Hann I; Liesner R
Br J Haematol; 2004 May; 125(3):366-8. PubMed ID: 15086418
[TBL] [Abstract][Full Text] [Related]
11. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.
Hay CR; Brown S; Collins PW; Keeling DM; Liesner R
Br J Haematol; 2006 Jun; 133(6):591-605. PubMed ID: 16704433
[TBL] [Abstract][Full Text] [Related]
12. The North American Immune Tolerance Registry: contributions to the thirty-year experience with immune tolerance therapy.
Dimichele D
Haemophilia; 2009 Jan; 15(1):320-8. PubMed ID: 18976249
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors in haemophilia B: the Italian experience.
Castaman G; Bonetti E; Messina M; Morfini M; Rocino A; Scaraggi FA; Tagariello G;
Haemophilia; 2013 Sep; 19(5):686-90. PubMed ID: 23601006
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors in young boys with haemophilia.
Lusher JM
Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):457-68. PubMed ID: 11030045
[TBL] [Abstract][Full Text] [Related]
15. Immune tolerance induction for a patient with factor IX inhibitors--a case report.
Nagel K; Laudenbach L; Rivard GE; Jardine L; Chan AK; Pai MK
Haemophilia; 2011 Mar; 17(2):315. PubMed ID: 20825499
[No Abstract] [Full Text] [Related]
16. Successful induction of immune tolerance with FIX recombinant in a patient with haemophilia B with inhibitor.
Soto I; Vicente JM; Corte JR; Urgellés MF; Pinto CR
Haemophilia; 2004 Jul; 10(4):401-4. PubMed ID: 15230957
[TBL] [Abstract][Full Text] [Related]
17. Inhibitor treatment in haemophilias A and B: inhibitor diagnosis.
DiMichele DM
Haemophilia; 2006 Dec; 12 Suppl 6():37-41; discussion 41-2. PubMed ID: 17123392
[TBL] [Abstract][Full Text] [Related]
18. Rituximab for adolescents with haemophilia and high titre inhibitors.
Fox RA; Neufeld EJ; Bennett CM
Haemophilia; 2006 May; 12(3):218-22. PubMed ID: 16643204
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporin A can achieve immune tolerance in a patient with severe haemophilia B and refractory inhibitors.
Cross DC; Van Der Berg HM
Haemophilia; 2007 Jan; 13(1):111-4. PubMed ID: 17212737
[TBL] [Abstract][Full Text] [Related]
20. Immune tolerance induction with mycophenolate-mofetil in two children with haemophilia B and inhibitor.
Klarmann D; Martinez Saguer I; Funk MB; Knoefler R; von Hentig N; Heller C; Kreuz W
Haemophilia; 2008 Jan; 14(1):44-9. PubMed ID: 18081836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]